{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:01:59Z","timestamp":1792008119891,"version":"4.4.0"},"reference-count":183,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:00:00Z","timestamp":1762646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:00:00Z","timestamp":1762646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"DOI":"10.1007\/s10147-025-02915-x","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:42:02Z","timestamp":1762674122000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sarcopenia in gastrointestinal cancers"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0285-0143","authenticated-orcid":false,"given":"Tomoya","family":"Emori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Itonaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Ashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,9]]},"reference":[{"key":"2915_CR1","doi-asserted-by":"publisher","first-page":"990s","DOI":"10.1093\/jn\/127.5.990S","volume":"127","author":"IH Rosenberg","year":"1997","unstructured":"Rosenberg IH (1997) Sarcopenia: origins and clinical relevance. J Nutr 127:990s\u2013991s","journal-title":"J Nutr"},{"key":"2915_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16\u201331","journal-title":"Age Ageing"},{"key":"2915_CR3","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"LK Chen","year":"2020","unstructured":"Chen LK, Woo J, Assantachai P et al (2020) Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 21:300-307.e2","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"2915_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","volume":"12","author":"RA Fielding","year":"2011","unstructured":"Fielding RA, Vellas B, Evans WJ et al (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12(4):249\u2013256","journal-title":"J Am Med Dir Assoc"},{"key":"2915_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40200-017-0302-x","volume":"16","author":"G Shafiee","year":"2017","unstructured":"Shafiee G, Keshtkar A, Soltani A et al (2017) Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies. J Diabetes Metab Disord 16:21","journal-title":"J Diabetes Metab Disord"},{"key":"2915_CR6","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/ageing\/afu115","volume":"43","author":"AJ Cruz-Jentoft","year":"2014","unstructured":"Cruz-Jentoft AJ, Landi F, Schneider SM et al (2014) Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the international sarcopenia initiative (EWGSOP and IWGS). Age Ageing 43:748\u2013759","journal-title":"Age Ageing"},{"key":"2915_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","volume":"15","author":"LK Chen","year":"2014","unstructured":"Chen LK, Liu LK, Woo J et al (2014) Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia. J Am Med Dir Assoc 15:95\u2013101","journal-title":"J Am Med Dir Assoc"},{"key":"2915_CR8","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/jpen.2415","volume":"46","author":"A Surov","year":"2022","unstructured":"Surov A, Wienke A (2022) Prevalence of sarcopenia in patients with solid tumors: a meta-analysis based on 81,814 patients. JPEN J Parenter Enteral Nutr 46:1761\u20131768","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"2915_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1080\/01635581.2024.2401648","volume":"77","author":"M Thormann","year":"2025","unstructured":"Thormann M, Meyer HJ, Wienke A et al (2025) The prevalence of sarcopenia in patients with solid tumors differs across regions: a systematic review. Nutr Cancer 77:102\u2013114","journal-title":"Nutr Cancer"},{"key":"2915_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12957-024-03304-w","volume":"22","author":"S Li","year":"2024","unstructured":"Li S, Xie K, Xiao X et al (2024) Correlation between sarcopenia and esophageal cancer: a narrative review. World J Surg Oncol 22:27","journal-title":"World J Surg Oncol"},{"key":"2915_CR11","doi-asserted-by":"publisher","first-page":"112107","DOI":"10.1016\/j.nut.2023.112107","volume":"114","author":"FM Zhang","year":"2023","unstructured":"Zhang FM, Song CH, Guo ZQ et al (2023) Sarcopenia prevalence in patients with cancer and association with adverse prognosis: a nationwide survey on common cancers. Nutrition 114:112107","journal-title":"Nutrition"},{"key":"2915_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3892\/ol.2023.13869","volume":"26","author":"J Liu","year":"2023","unstructured":"Liu J, Luo H, Huang L et al (2023) Prevalence of sarcopenia among patients with hepatocellular carcinoma: a systematic review and meta-analysis. Oncol Lett 26:283","journal-title":"Oncol Lett"},{"key":"2915_CR13","doi-asserted-by":"publisher","first-page":"102057","DOI":"10.1016\/j.arr.2023.102057","volume":"91","author":"FM Zhang","year":"2023","unstructured":"Zhang FM, Wu HF, Shi HP et al (2023) Sarcopenia and malignancies: epidemiology, clinical classification and implications. Ageing Res Rev 91:102057","journal-title":"Ageing Res Rev"},{"key":"2915_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14030711","author":"K S\u0131lay","year":"2025","unstructured":"S\u0131lay K, U\u00e7ar G, Eren T et al (2025) Could sarcopenia be related to chemotherapy in gastrointestinal cancer? A cross-sectional study including comprehensive geriatric assessment. J Clin Med. https:\/\/doi.org\/10.3390\/jcm14030711","journal-title":"J Clin Med"},{"key":"2915_CR15","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1002\/jcsm.13629","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhang J, Zhan Y et al (2024) Sarcopenia is a prognostic factor of adverse effects and mortality in patients with tumour: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 15:2295\u20132310","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2915_CR16","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/gerona\/glu010","volume":"69","author":"SA Studenski","year":"2014","unstructured":"Studenski SA, Peters KW, Alley DE et al (2014) The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 69:547\u2013558","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2915_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13092520","author":"B Pedauy\u00e9-Rueda","year":"2024","unstructured":"Pedauy\u00e9-Rueda B, Garc\u00eda-Fern\u00e1ndez P, Maicas-P\u00e9rez L et al (2024) Different diagnostic criteria for determining the prevalence of sarcopenia in older adults: a systematic review. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13092520","journal-title":"J Clin Med"},{"key":"2915_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/nu16030436","author":"G Voulgaridou","year":"2024","unstructured":"Voulgaridou G, Tyrovolas S, Detopoulou P et al (2024) Diagnostic criteria and measurement techniques of sarcopenia: a critical evaluation of the up-to-date evidence. Nutrients. https:\/\/doi.org\/10.3390\/nu16030436","journal-title":"Nutrients"},{"key":"2915_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/sjg.SJG_390_18","volume":"25","author":"K Shadhu","year":"2019","unstructured":"Shadhu K, Xi C (2019) Inflammation and pancreatic cancer: an updated review. Saudi J Gastroenterol 25:3\u201313","journal-title":"Saudi J Gastroenterol"},{"key":"2915_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.canlet.2020.04.017","volume":"484","author":"SK Shukla","year":"2020","unstructured":"Shukla SK, Markov SD, Attri KS et al (2020) Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia. Cancer Lett 484:29\u201339","journal-title":"Cancer Lett"},{"key":"2915_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239268","author":"VS Armstrong","year":"2020","unstructured":"Armstrong VS, Fitzgerald LW, Bathe OF (2020) Cancer-associated muscle wasting-candidate mechanisms and molecular pathways. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21239268","journal-title":"Int J Mol Sci"},{"key":"2915_CR22","doi-asserted-by":"publisher","first-page":"10308","DOI":"10.1038\/s41598-023-37470-w","volume":"13","author":"D Ai","year":"2023","unstructured":"Ai D, Ding N, Wu H (2023) The impact of sarcopenia on nutritional status in elderly patients with gastrointestinal tumors. Sci Rep 13:10308","journal-title":"Sci Rep"},{"key":"2915_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.clnu.2024.08.014","volume":"43","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhang L, Guan Y et al (2024) Establishment and validation of a risk prediction model for sarcopenia in gastrointestinal cancer patients: a systematic review and meta-analysis-based approach. Clin Nutr 43:91\u201398","journal-title":"Clin Nutr"},{"key":"2915_CR24","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/s12885-025-13837-2","volume":"25","author":"C Tian","year":"2025","unstructured":"Tian C, Li N, Gao Y et al (2025) The influencing factors of tumor-related sarcopenia: a scoping review. BMC Cancer 25:426","journal-title":"BMC Cancer"},{"key":"2915_CR25","first-page":"603","volume":"32","author":"S Sato","year":"2018","unstructured":"Sato S, Kunisaki C, Suematsu H et al (2018) Impact of sarcopenia in patients with unresectable locally advanced esophageal cancer receiving chemoradiotherapy. In Vivo 32:603\u2013610","journal-title":"In Vivo"},{"key":"2915_CR26","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3389\/fonc.2019.00366","volume":"9","author":"DW Ma","year":"2019","unstructured":"Ma DW, Cho Y, Jeon MJ et al (2019) Relationship between sarcopenia and prognosis in patient with concurrent chemo-radiation therapy for esophageal cancer. Front Oncol 9:366","journal-title":"Front Oncol"},{"key":"2915_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101647","author":"S Onishi","year":"2019","unstructured":"Onishi S, Tajika M, Tanaka T et al (2019) Prognostic significance of sarcopenia in patients with unresectable advanced esophageal cancer. J Clin Med. https:\/\/doi.org\/10.3390\/jcm8101647","journal-title":"J Clin Med"},{"key":"2915_CR28","doi-asserted-by":"publisher","first-page":"655071","DOI":"10.3389\/fonc.2021.655071","volume":"11","author":"YY Xu","year":"2021","unstructured":"Xu YY, Zhou XL, Yu CH et al (2021) Association of sarcopenia with toxicity and survival in postoperative recurrent esophageal squamous cell carcinoma patients receiving chemoradiotherapy. Front Oncol 11:655071","journal-title":"Front Oncol"},{"key":"2915_CR29","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1002\/jcsm.13082","volume":"13","author":"UM Jogiat","year":"2022","unstructured":"Jogiat UM, B\u00e9dard ELR, Sasewich H et al (2022) Sarcopenia reduces overall survival in unresectable oesophageal cancer: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 13:2630\u20132636","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2915_CR30","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s00330-015-3963-1","volume":"26","author":"D Tamandl","year":"2016","unstructured":"Tamandl D, Paireder M, Asari R et al (2016) Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer. Eur Radiol 26:1359\u20131367","journal-title":"Eur Radiol"},{"key":"2915_CR31","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ejso.2016.11.015","volume":"43","author":"M Paireder","year":"2017","unstructured":"Paireder M, Asari R, Kristo I et al (2017) Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer. Eur J Surg Oncol 43:478\u2013484","journal-title":"Eur J Surg Oncol"},{"key":"2915_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/icvts\/ivw274","volume":"24","author":"SY Park","year":"2017","unstructured":"Park SY, Yoon JK, Lee SJ et al (2017) Prognostic value of preoperative total psoas muscle area on long-term outcome in surgically treated oesophageal cancer patients. Interact Cardiovasc Thorac Surg 24:13\u201319","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2915_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12957-018-1327-4","volume":"16","author":"T J\u00e4rvinen","year":"2018","unstructured":"J\u00e4rvinen T, Ilonen I, Kauppi J et al (2018) Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study. World J Surg Oncol 16:27","journal-title":"World J Surg Oncol"},{"key":"2915_CR34","doi-asserted-by":"publisher","first-page":"449","DOI":"10.21873\/anticanres.13133","volume":"39","author":"T Matsunaga","year":"2019","unstructured":"Matsunaga T, Miyata H, Sugimura K et al (2019) Prognostic significance of sarcopenia and systemic inflammatory response in patients with esophageal cancer. Anticancer Res 39:449\u2013458","journal-title":"Anticancer Res"},{"key":"2915_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/doy104","author":"J Oguma","year":"2019","unstructured":"Oguma J, Ozawa S, Kazuno A et al (2019) Prognostic significance of sarcopenia in patients undergoing esophagectomy for superficial esophageal squamous cell carcinoma. Dis Esophagus. https:\/\/doi.org\/10.1093\/dote\/doy104","journal-title":"Dis Esophagus"},{"key":"2915_CR36","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.21873\/anticanres.14060","volume":"40","author":"CH Huang","year":"2020","unstructured":"Huang CH, Lue KH, Hsieh TC et al (2020) Association between sarcopenia and clinical outcomes in patients with esophageal cancer under neoadjuvant therapy. Anticancer Res 40:1175\u20131181","journal-title":"Anticancer Res"},{"key":"2915_CR37","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2478\/raon-2020-0016","volume":"54","author":"M Srpcic","year":"2020","unstructured":"Srpcic M, Jordan T, Popuri K et al (2020) Sarcopenia and myosteatosis at presentation adversely affect survival after esophagectomy for esophageal cancer. Radiol Oncol 54:237\u2013246","journal-title":"Radiol Oncol"},{"key":"2915_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040925","author":"HG Yoon","year":"2020","unstructured":"Yoon HG, Oh D, Ahn YC et al (2020) Prognostic impact of sarcopenia and skeletal muscle loss during neoadjuvant chemoradiotherapy in esophageal cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12040925","journal-title":"Cancers (Basel)"},{"key":"2915_CR39","doi-asserted-by":"publisher","first-page":"7185","DOI":"10.1245\/s10434-021-10025-x","volume":"28","author":"T Ishida","year":"2021","unstructured":"Ishida T, Makino T, Yamasaki M et al (2021) Quantity and quality of skeletal muscle as an important predictor of clinical outcomes in patients with esophageal cancer undergoing esophagectomy after neoadjuvant chemotherapy. Ann Surg Oncol 28:7185\u20137195","journal-title":"Ann Surg Oncol"},{"key":"2915_CR40","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1245\/s10434-022-11337-2","volume":"29","author":"A Watanabe","year":"2022","unstructured":"Watanabe A, Oshikiri T, Sawada R et al (2022) Actual sarcopenia reflects poor prognosis in patients with esophageal cancer. Ann Surg Oncol 29:3670\u20133681","journal-title":"Ann Surg Oncol"},{"key":"2915_CR41","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1245\/s10434-024-14936-3","volume":"31","author":"X Xiao","year":"2024","unstructured":"Xiao X, Fang PH, Zhou JF et al (2024) Impact of skeletal muscle loss and sarcopenia on outcomes of locally advanced esophageal cancer during neoadjuvant chemoradiation. Ann Surg Oncol 31:3819\u20133829","journal-title":"Ann Surg Oncol"},{"key":"2915_CR42","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1245\/s10434-023-14306-5","volume":"31","author":"T Kanemura","year":"2024","unstructured":"Kanemura T, Takeoka T, Sugase T et al (2024) Significance of comprehensive analysis of preoperative sarcopenia based on muscle mass, muscle strength, and physical function for the prognosis of patients with esophageal cancer. Ann Surg Oncol 31:818\u2013826","journal-title":"Ann Surg Oncol"},{"key":"2915_CR43","doi-asserted-by":"publisher","first-page":"15726","DOI":"10.1038\/s41598-025-00058-7","volume":"15","author":"J Merten","year":"2025","unstructured":"Merten J, Nacul Mora NG, Hoelzen JP et al (2025) Sarcopenia worsens overall survival following robotic esophagectomy for esophageal cancer. Sci Rep 15:15726","journal-title":"Sci Rep"},{"key":"2915_CR44","doi-asserted-by":"publisher","first-page":"doy115","DOI":"10.1093\/dote\/doy115","volume":"32","author":"HY Deng","year":"2019","unstructured":"Deng HY, Zha P, Peng L et al (2019) Preoperative sarcopenia is a predictor of poor prognosis of esophageal cancer after esophagectomy: a comprehensive systematic review and meta-analysis. Dis Esophagus 32:doy115","journal-title":"Dis Esophagus"},{"key":"2915_CR45","doi-asserted-by":"publisher","first-page":"619592","DOI":"10.3389\/fonc.2021.619592","volume":"11","author":"SB Jin","year":"2021","unstructured":"Jin SB, Tian ZB, Ding XL et al (2021) The impact of preoperative sarcopenia on survival prognosis in patients receiving neoadjuvant therapy for esophageal cancer: a systematic review and meta-analysis. Front Oncol 11:619592","journal-title":"Front Oncol"},{"key":"2915_CR46","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.1097\/SLA.0000000000005452","volume":"276","author":"UM Jogiat","year":"2022","unstructured":"Jogiat UM, Sasewich H, Turner SR et al (2022) Sarcopenia determined by skeletal muscle index predicts overall survival, disease-free survival, and postoperative complications in resectable esophageal cancer: a systematic review and meta-analysis. Ann Surg 276:e311\u2013e318","journal-title":"Ann Surg"},{"key":"2915_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jcsm.13126","volume":"14","author":"P Fang","year":"2023","unstructured":"Fang P, Zhou J, Xiao X et al (2023) The prognostic value of sarcopenia in oesophageal cancer: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 14:3\u201316","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2915_CR48","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.3892\/or.2015.4475","volume":"35","author":"N Hayashi","year":"2016","unstructured":"Hayashi N, Ando Y, Gyawali B et al (2016) Low skeletal muscle density is associated with poor survival in patients who receive chemotherapy for metastatic gastric cancer. Oncol Rep 35:1727\u20131731","journal-title":"Oncol Rep"},{"key":"2915_CR49","doi-asserted-by":"publisher","first-page":"e0202700","DOI":"10.1371\/journal.pone.0202700","volume":"13","author":"JS Lee","year":"2018","unstructured":"Lee JS, Kim YS, Kim EY et al (2018) Prognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer. PLoS ONE 13:e0202700","journal-title":"PLoS ONE"},{"key":"2915_CR50","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/jcsm.12371","volume":"10","author":"WPM Dijksterhuis","year":"2019","unstructured":"Dijksterhuis WPM, Pruijt MJ, van der Woude SO et al (2019) Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy. J Cachexia Sarcopenia Muscle 10:199\u2013206","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2915_CR51","doi-asserted-by":"publisher","first-page":"17683","DOI":"10.1038\/s41598-020-74765-8","volume":"10","author":"SE Park","year":"2020","unstructured":"Park SE, Choi JH, Park JY et al (2020) Loss of skeletal muscle mass during palliative chemotherapy is a poor prognostic factor in patients with advanced gastric cancer. Sci Rep 10:17683","journal-title":"Sci Rep"},{"key":"2915_CR52","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/cam4.3604","volume":"10","author":"LX Ma","year":"2021","unstructured":"Ma LX, Taylor K, Espin-Garcia O et al (2021) Prognostic significance of nutritional markers in metastatic gastric and esophageal adenocarcinoma. Cancer Med 10:199\u2013207","journal-title":"Cancer Med"},{"key":"2915_CR53","doi-asserted-by":"publisher","first-page":"e1272","DOI":"10.1093\/oncolo\/oyae123","volume":"29","author":"WL Chan","year":"2024","unstructured":"Chan WL, Yun HB, Cheung EE et al (2024) Association of sarcopenia with severe chemotherapy toxicities and survival in patients with advanced gastric cancer. Oncologist 29:e1272\u2013e1279","journal-title":"Oncologist"},{"key":"2915_CR54","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/j.clnu.2019.10.021","volume":"39","author":"E Rinninella","year":"2020","unstructured":"Rinninella E, Cintoni M, Raoul P et al (2020) Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: a systematic review and meta-analysis. Clin Nutr 39:2045\u20132054","journal-title":"Clin Nutr"},{"key":"2915_CR55","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1080\/01635581.2022.2077387","volume":"74","author":"HJ Meyer","year":"2022","unstructured":"Meyer HJ, Wienke A, Surov A (2022) Sarcopenia as a prognostic marker for survival in gastric cancer patients undergoing palliative chemotherapy. A systematic review and meta analysis. Nutr Cancer 74:3518\u20133526","journal-title":"Nutr Cancer"},{"key":"2915_CR56","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00423-016-1490-4","volume":"401","author":"FF Chen","year":"2016","unstructured":"Chen FF, Zhang FY, Zhou XY et al (2016) Role of frailty and nutritional status in predicting complications following total gastrectomy with D2 lymphadenectomy in patients with gastric cancer: a prospective study. Langenbecks Arch Surg 401:813\u2013822","journal-title":"Langenbecks Arch Surg"},{"key":"2915_CR57","doi-asserted-by":"publisher","first-page":"e3164","DOI":"10.1097\/MD.0000000000003164","volume":"95","author":"CL Zhuang","year":"2016","unstructured":"Zhuang CL, Huang DD, Pang WY et al (2016) Sarcopenia is an independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer: analysis from a large-scale cohort. Medicine (Baltimore) 95:e3164","journal-title":"Medicine (Baltimore)"},{"key":"2915_CR58","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1245\/s10434-017-5875-6","volume":"24","author":"K Sakurai","year":"2017","unstructured":"Sakurai K, Kubo N, Tamura T et al (2017) Adverse effects of low preoperative skeletal muscle mass in patients undergoing gastrectomy for gastric cancer. Ann Surg Oncol 24:2712\u20132719","journal-title":"Ann Surg Oncol"},{"key":"2915_CR59","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1245\/s10434-018-6624-1","volume":"25","author":"HS Park","year":"2018","unstructured":"Park HS, Kim HS, Beom SH et al (2018) Marked loss of muscle, visceral fat, or subcutaneous fat after gastrectomy predicts poor survival in advanced gastric cancer: single-center study from the CLASSIC trial. Ann Surg Oncol 25:3222\u20133230","journal-title":"Ann Surg Oncol"},{"key":"2915_CR60","first-page":"442","volume":"28","author":"CL Hu","year":"2019","unstructured":"Hu CL, Jin XH, Yuan ZD et al (2019) Prognostic significance of preoperative skeletal muscle status in patients with gastric cancer after radical gastrectomy. Asia Pac J Clin Nutr 28:442\u2013449","journal-title":"Asia Pac J Clin Nutr"},{"key":"2915_CR61","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/jso.25509","volume":"120","author":"M Sierzega","year":"2019","unstructured":"Sierzega M, Chrzan R, Wiktorowicz M et al (2019) Prognostic and predictive implications of sarcopenia in Western patients undergoing gastric resections for carcinoma of the stomach. J Surg Oncol 120:473\u2013482","journal-title":"J Surg Oncol"},{"key":"2915_CR62","doi-asserted-by":"publisher","first-page":"e23363","DOI":"10.1097\/MD.0000000000023363","volume":"99","author":"EY Kim","year":"2020","unstructured":"Kim EY, Jun KH, Kim SY et al (2020) Body mass index and skeletal muscle index are useful prognostic factors for overall survival after gastrectomy for gastric cancer: retrospective cohort study. Medicine (Baltimore) 99:e23363","journal-title":"Medicine (Baltimore)"},{"key":"2915_CR63","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00423-021-02092-1","volume":"406","author":"Y Taki","year":"2021","unstructured":"Taki Y, Sato S, Nakatani E et al (2021) Preoperative skeletal muscle index and visceral-to-subcutaneous fat area ratio are associated with long-term outcomes of elderly gastric cancer patients after gastrectomy. Langenbecks Arch Surg 406:463\u2013471","journal-title":"Langenbecks Arch Surg"},{"key":"2915_CR64","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/cam4.5040","volume":"12","author":"Q Wan","year":"2023","unstructured":"Wan Q, Wang Z, Zhao R et al (2023) CT-determined low skeletal muscle mass predicts worse overall survival of gastric cancer in patients with cachexia. Cancer Med 12:1492\u20131500","journal-title":"Cancer Med"},{"key":"2915_CR65","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00464-023-10638-1","volume":"38","author":"ZF Zheng","year":"2024","unstructured":"Zheng ZF, Lin GT, Zhong Q et al (2024) Effect of sarcopenia on short-term and long-term outcomes of older patients with locally advanced gastric cancer: a multicenter study. Surg Endosc 38:1151\u20131162","journal-title":"Surg Endosc"},{"key":"2915_CR66","doi-asserted-by":"publisher","first-page":"112408","DOI":"10.1016\/j.nut.2024.112408","volume":"123","author":"P Ding","year":"2024","unstructured":"Ding P, Wu H, Li T et al (2024) Impact of preoperative sarcopenia on postoperative complications and prognosis in patients undergoing robotic gastric cancer surgery: a propensity score matching study. Nutrition 123:112408","journal-title":"Nutrition"},{"key":"2915_CR67","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1007\/s11605-018-3856-0","volume":"22","author":"Z Yang","year":"2018","unstructured":"Yang Z, Zhou X, Ma B et al (2018) Predictive value of preoperative sarcopenia in patients with gastric cancer: a meta-analysis and systematic review. J Gastrointest Surg 22:1890\u20131902","journal-title":"J Gastrointest Surg"},{"key":"2915_CR68","doi-asserted-by":"publisher","first-page":"109569","DOI":"10.1016\/j.ejso.2024.109569","volume":"51","author":"C Liu","year":"2025","unstructured":"Liu C, Li Y, Xu Y et al (2025) The impact of preoperative skeletal muscle mass index-defined sarcopenia on postoperative complications and survival in gastric cancer: an updated meta-analysis. Eur J Surg Oncol 51:109569","journal-title":"Eur J Surg Oncol"},{"key":"2915_CR69","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12885-019-5319-8","volume":"19","author":"N Charette","year":"2019","unstructured":"Charette N, Vandeputte C, Ameye L et al (2019) Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials. BMC Cancer 19:134","journal-title":"BMC Cancer"},{"key":"2915_CR70","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10147-020-01805-8","volume":"26","author":"Y Murachi","year":"2021","unstructured":"Murachi Y, Sakai D, Koseki J et al (2021) Impact of sarcopenia in patients with advanced or recurrent colorectal cancer treated with regorafenib. Int J Clin Oncol 26:409\u2013416","journal-title":"Int J Clin Oncol"},{"key":"2915_CR71","doi-asserted-by":"publisher","first-page":"671547","DOI":"10.3389\/fnut.2021.671547","volume":"8","author":"DD da Silva","year":"2021","unstructured":"da Silva DD, Machado M, Trabulo C et al (2021) Impact of body composition on prognosis and dose-limiting toxicities on metastatic colorectal cancer. Front Nutr 8:671547","journal-title":"Front Nutr"},{"key":"2915_CR72","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s00384-024-04747-z","volume":"39","author":"W Tang","year":"2024","unstructured":"Tang W, Li F, Zheng H et al (2024) Prognostic value of baseline skeletal muscle index in colorectal cancer patients treated with fruquintinib: a multi-center real world analysis. Int J Colorectal Dis 39:186","journal-title":"Int J Colorectal Dis"},{"key":"2915_CR73","first-page":"e213","volume":"21","author":"HJ Meyer","year":"2022","unstructured":"Meyer HJ, Strobel A, Wienke A et al (2022) Prognostic role of low-skeletal muscle mass on staging computed tomography in metastasized colorectal cancer: a systematic review and meta-analysis. Clin Colorectal Cancer 21:e213\u2013e225","journal-title":"Clin Colorectal Cancer"},{"key":"2915_CR74","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1245\/s10434-014-4281-6","volume":"22","author":"Y Miyamoto","year":"2015","unstructured":"Miyamoto Y, Baba Y, Sakamoto Y et al (2015) Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol 22:2663\u20132668","journal-title":"Ann Surg Oncol"},{"key":"2915_CR75","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/bjs.10075","volume":"103","author":"G Malietzis","year":"2016","unstructured":"Malietzis G, Currie AC, Athanasiou T et al (2016) Influence of body composition profile on outcomes following colorectal cancer surgery. Br J Surg 103:572\u2013580","journal-title":"Br J Surg"},{"key":"2915_CR76","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/jcsm.12234","volume":"9","author":"MH Choi","year":"2018","unstructured":"Choi MH, Oh SN, Lee IK et al (2018) Sarcopenia is negatively associated with long-term outcomes in locally advanced rectal cancer. J Cachexia Sarcopenia Muscle 9:53\u201359","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2915_CR77","doi-asserted-by":"publisher","first-page":"e13363","DOI":"10.1097\/MD.0000000000013363","volume":"97","author":"SE Park","year":"2018","unstructured":"Park SE, Hwang IG, Choi CH et al (2018) Sarcopenia is poor prognostic factor in older patients with locally advanced rectal cancer who received preoperative or postoperative chemoradiotherapy. Medicine (Baltimore) 97:e13363","journal-title":"Medicine (Baltimore)"},{"key":"2915_CR78","doi-asserted-by":"publisher","first-page":"e0195406","DOI":"10.1371\/journal.pone.0195406","volume":"13","author":"Y Takeda","year":"2018","unstructured":"Takeda Y, Akiyoshi T, Matsueda K et al (2018) Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy. PLoS ONE 13:e0195406","journal-title":"PLoS ONE"},{"key":"2915_CR79","doi-asserted-by":"publisher","first-page":"563","DOI":"10.4143\/crt.2019.249","volume":"52","author":"JS Han","year":"2020","unstructured":"Han JS, Ryu H, Park IJ et al (2020) Association of body composition with long-term survival in non-metastatic rectal cancer patients. Cancer Res Treat 52:563\u2013572","journal-title":"Cancer Res Treat"},{"key":"2915_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102410","author":"C Lee","year":"2021","unstructured":"Lee C, Park IJ, Kim KW et al (2021) Influence of postoperative changes in sarcopenia on long-term survival in non-metastatic colorectal cancer patients. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13102410","journal-title":"Cancers (Basel)"},{"key":"2915_CR81","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10147-021-02062-z","volume":"27","author":"S Abe","year":"2022","unstructured":"Abe S, Kawai K, Nozawa H et al (2022) Preoperative sarcopenia is a poor prognostic factor in lower rectal cancer patients undergoing neoadjuvant chemoradiotherapy: a retrospective study. Int J Clin Oncol 27:141\u2013153","journal-title":"Int J Clin Oncol"},{"key":"2915_CR82","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1111\/ans.18269","volume":"93","author":"G Portale","year":"2023","unstructured":"Portale G, Zuin M, Spolverato YC et al (2023) Prognostic effect of sarcopenia in patients undergoing laparoscopic rectal cancer resection. ANZ J Surg 93:1631\u20131637","journal-title":"ANZ J Surg"},{"key":"2915_CR83","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1111\/ans.18512","volume":"93","author":"R Gartrell","year":"2023","unstructured":"Gartrell R, Qiao J, Kiss N et al (2023) Can sarcopenia predict survival in locally advanced rectal cancer patients? ANZ J Surg 93:2166\u20132171","journal-title":"ANZ J Surg"},{"key":"2915_CR84","doi-asserted-by":"publisher","first-page":"1076589","DOI":"10.3389\/fnut.2023.1076589","volume":"10","author":"H Xie","year":"2023","unstructured":"Xie H, Wei L, Gao S et al (2023) Prognostic significance of sarcopenia diagnosed based on the anthropometric equation for progression-free survival and overall survival in patients with colorectal cancer. Front Nutr 10:1076589","journal-title":"Front Nutr"},{"key":"2915_CR85","doi-asserted-by":"publisher","first-page":"e0303494","DOI":"10.1371\/journal.pone.0303494","volume":"19","author":"Q Su","year":"2024","unstructured":"Su Q, Shen J (2024) Predictive role of preoperative sarcopenia for long-term survival in rectal cancer patients: a meta-analysis. PLoS ONE 19:e0303494","journal-title":"PLoS ONE"},{"key":"2915_CR86","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1111\/jgh.16681","volume":"39","author":"WL Lin","year":"2024","unstructured":"Lin WL, Nguyen TH, Huang WT et al (2024) Sarcopenia and survival in colorectal cancer without distant metastasis: a systematic review and meta-analysis. J Gastroenterol Hepatol 39:2250\u20132259","journal-title":"J Gastroenterol Hepatol"},{"key":"2915_CR87","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12029-025-01267-z","volume":"56","author":"C Atuiri","year":"2025","unstructured":"Atuiri C, Ngang IC, Appiah D et al (2025) Pretreatment skeletal muscle index and survival outcomes in non-metastatic colorectal cancer: a systematic review and meta-analysis. J Gastrointest Cancer 56:143","journal-title":"J Gastrointest Cancer"},{"key":"2915_CR88","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/hepr.12780","volume":"47","author":"A Hiraoka","year":"2017","unstructured":"Hiraoka A, Hirooka M, Koizumi Y et al (2017) Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib. Hepatol Res 47:558\u2013565","journal-title":"Hepatol Res"},{"key":"2915_CR89","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3892\/ol.2017.6287","volume":"14","author":"H Nishikawa","year":"2017","unstructured":"Nishikawa H, Nishijima N, Enomoto H et al (2017) Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy. Oncol Lett 14:1637\u20131647","journal-title":"Oncol Lett"},{"key":"2915_CR90","first-page":"291","volume":"71","author":"A Naganuma","year":"2017","unstructured":"Naganuma A, Hoshino T, Suzuki Y et al (2017) Association between skeletal muscle depletion and sorafenib treatment in male patients with hepatocellular carcinoma: a retrospective cohort study. Acta Med Okayama 71:291\u2013299","journal-title":"Acta Med Okayama"},{"key":"2915_CR91","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1177\/2050640618781188","volume":"6","author":"G Antonelli","year":"2018","unstructured":"Antonelli G, Gigante E, Iavarone M et al (2018) Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment. United Eur Gastroenterol J 6:1039\u20131048","journal-title":"United Eur Gastroenterol J"},{"key":"2915_CR92","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/jgh3.12167","volume":"3","author":"K Sawada","year":"2019","unstructured":"Sawada K, Saitho Y, Hayashi H et al (2019) Skeletal muscle mass is associated with toxicity, treatment tolerability, and additional or subsequent therapies in patients with hepatocellular carcinoma receiving sorafenib treatment. JGH Open 3:329\u2013337","journal-title":"JGH Open"},{"key":"2915_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082146","author":"K Endo","year":"2020","unstructured":"Endo K, Kuroda H, Kanazawa J et al (2020) Impact of grip strength in patients with unresectable hepatocellular carcinoma treated with lenvatinib. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12082146","journal-title":"Cancers (Basel)"},{"key":"2915_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092247","author":"I Saeki","year":"2021","unstructured":"Saeki I, Yamasaki T, Yamauchi Y et al (2021) Skeletal muscle volume is an independent predictor of survival after Sorafenib treatment failure for hepatocellular carcinoma. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13092247","journal-title":"Cancers (Basel)"},{"key":"2915_CR95","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1111\/jgh.15336","volume":"36","author":"A Hiraoka","year":"2021","unstructured":"Hiraoka A, Kumada T, Kariyama K et al (2021) Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: analysis adjusted with inverse probability weighting. J Gastroenterol Hepatol 36:1812\u20131819","journal-title":"J Gastroenterol Hepatol"},{"key":"2915_CR96","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/COC.0000000000000787","volume":"44","author":"M Akce","year":"2021","unstructured":"Akce M, Liu Y, Zakka K et al (2021) Impact of sarcopenia, BMI, and inflammatory biomarkers on survival in advanced hepatocellular carcinoma treated with anti-PD-1 antibody. Am J Clin Oncol 44:74\u201381","journal-title":"Am J Clin Oncol"},{"key":"2915_CR97","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00262-020-02794-3","volume":"70","author":"N Kim","year":"2021","unstructured":"Kim N, Yu JI, Park HC et al (2021) Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumab. Cancer Immunol Immunother 70:1593\u20131603","journal-title":"Cancer Immunol Immunother"},{"key":"2915_CR98","doi-asserted-by":"publisher","first-page":"e28680","DOI":"10.1097\/MD.0000000000028680","volume":"101","author":"D Dong","year":"2022","unstructured":"Dong D, Shi JY, Shang X et al (2022) Prognostic significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib: a retrospective analysis. Medicine (Baltimore) 101:e28680","journal-title":"Medicine (Baltimore)"},{"key":"2915_CR99","doi-asserted-by":"publisher","first-page":"6479","DOI":"10.1038\/s41598-022-10514-3","volume":"12","author":"M Fujita","year":"2022","unstructured":"Fujita M, Abe K, Kuroda H et al (2022) Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, Japan. Sci Rep 12:6479","journal-title":"Sci Rep"},{"key":"2915_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15123243","author":"K Oura","year":"2023","unstructured":"Oura K, Morishita A, Manabe T et al (2023) Relationship between accurate diagnosis of sarcopenia and prognosis in patients with hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab combination therapy. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15123243","journal-title":"Cancers (Basel)"},{"key":"2915_CR101","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s00330-022-08980-4","volume":"33","author":"BB Chen","year":"2023","unstructured":"Chen BB, Liang PC, Shih TT et al (2023) Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma. Eur Radiol 33:512\u2013522","journal-title":"Eur Radiol"},{"key":"2915_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15092426","author":"MH Kuo","year":"2023","unstructured":"Kuo MH, Tseng CW, Hsu CS et al (2023) Prevalence and effect of low skeletal muscle mass among hepatocellular carcinoma patients undergoing systemic therapy: a systematic review and meta-analysis. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15092426","journal-title":"Cancers (Basel)"},{"key":"2915_CR103","doi-asserted-by":"publisher","first-page":"2395062","DOI":"10.1080\/07853890.2024.2395062","volume":"56","author":"L Zhang","year":"2024","unstructured":"Zhang L, Li X, Wang K et al (2024) Prognostic impact of body composition in hepatocellular carcinoma patients with immunotherapy. Ann Med 56:2395062","journal-title":"Ann Med"},{"key":"2915_CR104","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1002\/bjs.9258","volume":"100","author":"N Harimoto","year":"2013","unstructured":"Harimoto N, Shirabe K, Yamashita YI et al (2013) Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg 100:1523\u20131530","journal-title":"Br J Surg"},{"key":"2915_CR105","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1097\/SLA.0000000000000743","volume":"261","author":"T Voron","year":"2015","unstructured":"Voron T, Tselikas L, Pietrasz D et al (2015) Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg 261:1173\u20131183","journal-title":"Ann Surg"},{"key":"2915_CR106","first-page":"363","volume":"70","author":"K Takagi","year":"2016","unstructured":"Takagi K, Yagi T, Yoshida R et al (2016) Sarcopenia and american society of anesthesiologists physical status in the assessment of outcomes of hepatocellular carcinoma patients undergoing hepatectomy. Acta Med Okayama 70:363\u2013370","journal-title":"Acta Med Okayama"},{"key":"2915_CR107","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.hbpd.2018.07.008","volume":"18","author":"A Kroh","year":"2019","unstructured":"Kroh A, Uschner D, Lodewick T et al (2019) Impact of body composition on survival and morbidity after liver resection in hepatocellular carcinoma patients. Hepatobiliary Pancreat Dis Int 18:28\u201337","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"2915_CR108","doi-asserted-by":"publisher","first-page":"744","DOI":"10.21037\/jgo-21-802","volume":"13","author":"H Kim","year":"2022","unstructured":"Kim H, Choi HZ, Choi JM et al (2022) Sarcopenia with systemic inflammation can predict survival in patients with hepatocellular carcinoma undergoing curative resection. J Gastrointest Oncol 13:744\u2013753","journal-title":"J Gastrointest Oncol"},{"key":"2915_CR109","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.asjsur.2022.07.122","volume":"46","author":"H Hayashi","year":"2023","unstructured":"Hayashi H, Shimizu A, Kubota K et al (2023) Combination of sarcopenia and prognostic nutritional index to predict long-term outcomes in patients undergoing initial hepatectomy for hepatocellular carcinoma. Asian J Surg 46:816\u2013823","journal-title":"Asian J Surg"},{"key":"2915_CR110","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1080\/01635581.2022.2159046","volume":"75","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhang L, Wang Y et al (2023) Sarcopenia predicts prognosis of patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis. Nutr Cancer 75:776\u2013784","journal-title":"Nutr Cancer"},{"key":"2915_CR111","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.acra.2023.11.040","volume":"31","author":"Q Kong","year":"2024","unstructured":"Kong Q, Gao Q, Li W et al (2024) The impact of imaging-diagnosed sarcopenia on long-term prognosis after curative resection for hepatocellular carcinoma: a systematic review and meta-analysis. Acad Radiol 31:1272\u20131283","journal-title":"Acad Radiol"},{"key":"2915_CR112","doi-asserted-by":"publisher","first-page":"79441","DOI":"10.18632\/oncotarget.18345","volume":"8","author":"KM Cho","year":"2017","unstructured":"Cho KM, Park H, Oh DY et al (2017) Skeletal muscle depletion predicts survival of patients with advanced biliary tract cancer undergoing palliative chemotherapy. Oncotarget 8:79441\u201379452","journal-title":"Oncotarget"},{"key":"2915_CR113","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3389\/fonc.2020.01581","volume":"10","author":"BM Lee","year":"2020","unstructured":"Lee BM, Cho Y, Kim JW et al (2020) Prognostic significance of sarcopenia in advanced biliary tract cancer patients. Front Oncol 10:1581","journal-title":"Front Oncol"},{"key":"2915_CR114","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.21873\/invivo.12581","volume":"35","author":"K Meguro","year":"2021","unstructured":"Meguro K, Hosono K, Sato M et al (2021) Prognostic impact of sarcopenia in patients with biliary tract cancer undergoing chemotherapy. In Vivo 35:2909\u20132915","journal-title":"In Vivo"},{"key":"2915_CR115","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10194340","author":"MS J\u00f6rdens","year":"2021","unstructured":"J\u00f6rdens MS, Wittig L, Heinrichs L et al (2021) Sarcopenia and myosteatosis as prognostic markers in patients with advanced cholangiocarcinoma undergoing palliative treatment. J Clin Med. https:\/\/doi.org\/10.3390\/jcm10194340","journal-title":"J Clin Med"},{"key":"2915_CR116","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10147-023-02466-z","volume":"29","author":"S Takaoka","year":"2024","unstructured":"Takaoka S, Hamada T, Takahara N et al (2024) Skeletal muscle status and survival among patients with advanced biliary tract cancer. Int J Clin Oncol 29:297\u2013308","journal-title":"Int J Clin Oncol"},{"key":"2915_CR117","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/hpb.12394","volume":"17","author":"RJ Coelen","year":"2015","unstructured":"Coelen RJ, Wiggers JK, Nio CY et al (2015) Preoperative computed tomography assessment of skeletal muscle mass is valuable in predicting outcomes following hepatectomy for perihilar cholangiocarcinoma. HPB (Oxford) 17:520\u2013528","journal-title":"HPB (Oxford)"},{"key":"2915_CR118","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.surg.2015.08.047","volume":"159","author":"S Okumura","year":"2016","unstructured":"Okumura S, Kaido T, Hamaguchi Y et al (2016) Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies. Surgery 159:821\u2013833","journal-title":"Surgery"},{"key":"2915_CR119","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1245\/s10434-016-5668-3","volume":"24","author":"S Okumura","year":"2017","unstructured":"Okumura S, Kaido T, Hamaguchi Y et al (2017) Impact of skeletal muscle mass, muscle quality, and visceral adiposity on outcomes following resection of intrahepatic cholangiocarcinoma. Ann Surg Oncol 24:1037\u20131045","journal-title":"Ann Surg Oncol"},{"key":"2915_CR120","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/liv.14132","volume":"39","author":"F Hahn","year":"2019","unstructured":"Hahn F, M\u00fcller L, St\u00f6hr F et al (2019) The role of sarcopenia in patients with intrahepatic cholangiocarcinoma: prognostic marker or hyped parameter? Liver Int 39:1307\u20131314","journal-title":"Liver Int"},{"key":"2915_CR121","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/jcsm.12431","volume":"10","author":"SB Yoon","year":"2019","unstructured":"Yoon SB, Choi MH, Song M et al (2019) Impact of preoperative body compositions on survival following resection of biliary tract cancer. J Cachexia Sarcopenia Muscle 10:794\u2013802","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2915_CR122","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s11605-019-04198-w","volume":"24","author":"EC Lee","year":"2020","unstructured":"Lee EC, Park SJ, Lee SD et al (2020) Effects of sarcopenia on prognosis after resection of gallbladder cancer. J Gastrointest Surg 24:1082\u20131091","journal-title":"J Gastrointest Surg"},{"key":"2915_CR123","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1016\/j.clnu.2020.12.011","volume":"40","author":"S Tamura","year":"2021","unstructured":"Tamura S, Ashida R, Sugiura T et al (2021) The prognostic impact of skeletal muscle status and bone mineral density for resected distal cholangiocarcinoma. Clin Nutr 40:3552\u20133558","journal-title":"Clin Nutr"},{"key":"2915_CR124","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/jhbp.1220","volume":"30","author":"Y Asai","year":"2023","unstructured":"Asai Y, Yamaguchi J, Mizuno T et al (2023) Impact of preoperative muscle mass and quality on surgical outcomes in patients undergoing major hepatectomy for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 30:202\u2013211","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2915_CR125","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s12029-024-01034-6","volume":"55","author":"M Utsumi","year":"2024","unstructured":"Utsumi M, Inagaki M, Kitada K et al (2024) Prognostic significance of sarcopenia and systemic inflammatory markers in biliary tract cancer: a retrospective cohort study. J Gastrointest Cancer 55:888\u2013899","journal-title":"J Gastrointest Cancer"},{"key":"2915_CR126","doi-asserted-by":"publisher","first-page":"e6878","DOI":"10.1002\/cam4.6878","volume":"13","author":"G Wang","year":"2024","unstructured":"Wang G, Mantas A, Heij LR et al (2024) Body composition is associated with postoperative complications in perihilar cholangiocarcinoma. Cancer Med 13:e6878","journal-title":"Cancer Med"},{"key":"2915_CR127","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.hpb.2021.11.012","volume":"24","author":"A Surov","year":"2022","unstructured":"Surov A, Pech M, Omari J et al (2022) Low skeletal muscle mass in cholangiocarcinoma treated by surgical resection. A meta-analysis. HPB (Oxford) 24:997\u20131006","journal-title":"HPB (Oxford)"},{"key":"2915_CR128","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12957-024-03516-0","volume":"22","author":"J Ji","year":"2024","unstructured":"Ji J, Mi S, Hou Z et al (2024) Impact of imaging-diagnosed sarcopenia on outcomes in patients with biliary tract cancer after surgical resection: a systematic review and meta-analysis. World J Surg Oncol 22:229","journal-title":"World J Surg Oncol"},{"key":"2915_CR129","doi-asserted-by":"publisher","first-page":"e0139749","DOI":"10.1371\/journal.pone.0139749","volume":"10","author":"Y Choi","year":"2015","unstructured":"Choi Y, Oh DY, Kim TY et al (2015) Skeletal muscle depletion predicts the prognosis of patients with advanced pancreatic cancer undergoing palliative chemotherapy, independent of body mass index. PLoS ONE 10:e0139749","journal-title":"PLoS ONE"},{"key":"2915_CR130","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.4143\/crt.2015.250","volume":"48","author":"I Park","year":"2016","unstructured":"Park I, Choi SJ, Kim YS et al (2016) Prognostic factors for risk stratification of patients with recurrent or metastatic pancreatic adenocarcinoma who were treated with gemcitabine-based chemotherapy. Cancer Res Treat 48:1264\u20131273","journal-title":"Cancer Res Treat"},{"key":"2915_CR131","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pan.2018.11.001","volume":"19","author":"Y Kurita","year":"2019","unstructured":"Kurita Y, Kobayashi N, Tokuhisa M et al (2019) Sarcopenia is a reliable prognostic factor in patients with advanced pancreatic cancer receiving FOLFIRINOX chemotherapy. Pancreatology 19:127\u2013135","journal-title":"Pancreatology"},{"key":"2915_CR132","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12885-020-07753-w","volume":"21","author":"IH Kim","year":"2021","unstructured":"Kim IH, Choi MH, Lee IS et al (2021) Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study. BMC Cancer 21:77","journal-title":"BMC Cancer"},{"key":"2915_CR133","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.pan.2021.03.002","volume":"21","author":"H Sato","year":"2021","unstructured":"Sato H, Goto T, Hayashi A et al (2021) Prognostic significance of skeletal muscle decrease in unresectable pancreatic cancer: survival analysis using the Weibull exponential distribution model. Pancreatology 21:892\u2013902","journal-title":"Pancreatology"},{"key":"2915_CR134","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1017\/S0007114520003463","volume":"125","author":"S Uemura","year":"2021","unstructured":"Uemura S, Iwashita T, Ichikawa H et al (2021) The impact of sarcopenia and decrease in skeletal muscle mass in patients with advanced pancreatic cancer during FOLFIRINOX therapy. Br J Nutr 125:1140\u20131147","journal-title":"Br J Nutr"},{"key":"2915_CR135","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pan.2021.12.013","volume":"22","author":"T Emori","year":"2022","unstructured":"Emori T, Itonaga M, Ashida R et al (2022) Impact of sarcopenia on prediction of progression-free survival and overall survival of patients with pancreatic ductal adenocarcinoma receiving first-line gemcitabine and nab-paclitaxel chemotherapy. Pancreatology 22:277\u2013285","journal-title":"Pancreatology"},{"key":"2915_CR136","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/MPA.0000000000001985","volume":"51","author":"H Asama","year":"2022","unstructured":"Asama H, Ueno M, Kobayashi S et al (2022) Sarcopenia: prognostic value for unresectable pancreatic ductal adenocarcinoma patients treated with gemcitabine plus Nab-paclitaxel. Pancreas 51:148\u2013152","journal-title":"Pancreas"},{"key":"2915_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133137","author":"YC Hou","year":"2022","unstructured":"Hou YC, Chen CY, Huang CJ et al (2022) The differential clinical impacts of cachexia and sarcopenia on the prognosis of advanced pancreatic cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14133137","journal-title":"Cancers (Basel)"},{"key":"2915_CR138","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3892\/ol.2022.13495","volume":"24","author":"Y Tozuka","year":"2022","unstructured":"Tozuka Y, Ueno M, Kobayashi S et al (2022) Prognostic significance of sarcopenia as determined by bioelectrical impedance analysis in patients with advanced pancreatic cancer receiving gemcitabine plus nab-paclitaxel: a retrospective study. Oncol Lett 24:375","journal-title":"Oncol Lett"},{"key":"2915_CR139","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.2169\/internalmedicine.0900-22","volume":"62","author":"A Ishizaki","year":"2023","unstructured":"Ishizaki A, Okuwaki K, Kida M et al (2023) Implication of skeletal muscle loss in the prognosis of patients with pancreatic ductal adenocarcinoma receiving chemotherapy. Intern Med 62:2783\u20132793","journal-title":"Intern Med"},{"key":"2915_CR140","first-page":"197","volume":"31","author":"Y Suzuki","year":"2023","unstructured":"Suzuki Y, Saito K, Nakai Y et al (2023) Early skeletal muscle mass decline is a prognostic factor in patients receiving gemcitabine plus nab-paclitaxel for unresectable pancreatic cancer: a retrospective observational study. Support Care Cancer 31:197","journal-title":"Support Care Cancer"},{"key":"2915_CR141","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-025-02283-3","author":"T Emori","year":"2025","unstructured":"Emori T, Itonaga M, Ashida R et al (2025) Impact of sarcopenia and changes in skeletal muscle mass on prognosis of patients with pancreatic ductal adenocarcinoma receiving chemotherapy with first-line gemcitabine and nab-paclitaxel: a prospective study. J Gastroenterol. https:\/\/doi.org\/10.1007\/s00535-025-02283-3","journal-title":"J Gastroenterol"},{"key":"2915_CR142","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1007\/s11605-012-1923-5","volume":"16","author":"P Peng","year":"2012","unstructured":"Peng P, Hyder O, Firoozmand A et al (2012) Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg 16:1478\u20131486","journal-title":"J Gastrointest Surg"},{"key":"2915_CR143","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.surg.2015.02.002","volume":"157","author":"S Okumura","year":"2015","unstructured":"Okumura S, Kaido T, Hamaguchi Y et al (2015) Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery 157:1088\u20131098","journal-title":"Surgery"},{"key":"2915_CR144","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s11605-015-2835-y","volume":"19","author":"N Amini","year":"2015","unstructured":"Amini N, Spolverato G, Gupta R et al (2015) Impact total psoas volume on short- and long-term outcomes in patients undergoing curative resection for pancreatic adenocarcinoma: a new tool to assess sarcopenia. J Gastrointest Surg 19:1593\u20131602","journal-title":"J Gastrointest Surg"},{"key":"2915_CR145","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijsu.2017.01.075","volume":"39","author":"G Ninomiya","year":"2017","unstructured":"Ninomiya G, Fujii T, Yamada S et al (2017) Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: a retrospective cohort study. Int J Surg 39:45\u201351","journal-title":"Int J Surg"},{"key":"2915_CR146","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1245\/s10434-017-6077-y","volume":"24","author":"S Okumura","year":"2017","unstructured":"Okumura S, Kaido T, Hamaguchi Y et al (2017) Visceral adiposity and sarcopenic visceral obesity are associated with poor prognosis after resection of pancreatic cancer. Ann Surg Oncol 24:3732\u20133740","journal-title":"Ann Surg Oncol"},{"key":"2915_CR147","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/jcsm.12274","volume":"9","author":"MH Choi","year":"2018","unstructured":"Choi MH, Yoon SB, Lee K et al (2018) Preoperative sarcopenia and post-operative accelerated muscle loss negatively impact survival after resection of pancreatic cancer. J Cachexia Sarcopenia Muscle 9:326\u2013334","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2915_CR148","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s11605-018-3695-z","volume":"22","author":"M Sugimoto","year":"2018","unstructured":"Sugimoto M, Farnell MB, Nagorney DM et al (2018) Decreased skeletal muscle volume is a predictive factor for poorer survival in patients undergoing surgical resection for pancreatic ductal adenocarcinoma. J Gastrointest Surg 22:831\u2013839","journal-title":"J Gastrointest Surg"},{"key":"2915_CR149","doi-asserted-by":"publisher","first-page":"e0215915","DOI":"10.1371\/journal.pone.0215915","volume":"14","author":"ES Gruber","year":"2019","unstructured":"Gruber ES, Jomrich G, Tamandl D et al (2019) Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma. PLoS ONE 14:e0215915","journal-title":"PLoS ONE"},{"key":"2915_CR150","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.4240\/wjgs.v14.i12.1350","volume":"14","author":"ZW Cai","year":"2022","unstructured":"Cai ZW, Li JL, Liu M et al (2022) Low preoperative skeletal muscle index increases the risk of mortality among resectable pancreatic cancer patients: a retrospective study. World J Gastrointest Surg 14:1350\u20131362","journal-title":"World J Gastrointest Surg"},{"key":"2915_CR151","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1080\/01635581.2020.1870704","volume":"74","author":"K Jin","year":"2022","unstructured":"Jin K, Tang Y, Wang A et al (2022) Body composition and response and outcome of neoadjuvant treatment for pancreatic cancer. Nutr Cancer 74:100\u2013109","journal-title":"Nutr Cancer"},{"key":"2915_CR152","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3348\/kjr.2022.0277","volume":"23","author":"DW Kim","year":"2022","unstructured":"Kim DW, Ahn H, Kim KW et al (2022) Prognostic value of sarcopenia and myosteatosis in patients with resectable pancreatic ductal adenocarcinoma. Korean J Radiol 23:1055\u20131066","journal-title":"Korean J Radiol"},{"key":"2915_CR153","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1245\/s10434-021-10995-y","volume":"29","author":"H Rom","year":"2022","unstructured":"Rom H, Tamir S, Van Vugt JLA et al (2022) Sarcopenia as a predictor of survival in patients with pancreatic adenocarcinoma after pancreatectomy. Ann Surg Oncol 29:1553\u20131563","journal-title":"Ann Surg Oncol"},{"key":"2915_CR154","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.1245\/s10434-023-13569-2","volume":"30","author":"S Masuda","year":"2023","unstructured":"Masuda S, Yamakawa K, Masuda A et al (2023) Association of sarcopenia with a poor prognosis and decreased tumor-infiltrating CD8-positive T cells in pancreatic ductal adenocarcinoma: a retrospective analysis. Ann Surg Oncol 30:5776\u20135787","journal-title":"Ann Surg Oncol"},{"key":"2915_CR155","doi-asserted-by":"publisher","first-page":"10438","DOI":"10.1002\/cam4.5779","volume":"12","author":"XD Shen","year":"2023","unstructured":"Shen XD, Wang X, Zheng ZJ et al (2023) The differential effects of sarcopenia and cachexia on overall survival for pancreatic ductal adenocarcinoma patients following pancreatectomy: a retrospective study based on a large population. Cancer Med 12:10438\u201310448","journal-title":"Cancer Med"},{"key":"2915_CR156","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.pan.2023.05.006","volume":"23","author":"D Tazeoglu","year":"2023","unstructured":"Tazeoglu D, Benli S, Colak T et al (2023) Comparative analysis of the sarcopenia and HALP score on postoperative outcomes in pancreatic cancer patients after pancreatoduodenectomy. Pancreatology 23:530\u2013536","journal-title":"Pancreatology"},{"key":"2915_CR157","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12957-024-03310-y","volume":"22","author":"C Liu","year":"2024","unstructured":"Liu C, An L, Zhang S et al (2024) Association between preoperative sarcopenia and prognosis of pancreatic cancer after curative-intent surgery: a updated systematic review and meta-analysis. World J Surg Oncol 22:38","journal-title":"World J Surg Oncol"},{"key":"2915_CR158","doi-asserted-by":"publisher","first-page":"6126","DOI":"10.1097\/JS9.0000000000000989","volume":"110","author":"P Raoul","year":"2024","unstructured":"Raoul P, Cintoni M, Coppola A et al (2024) Preoperative low skeletal muscle mass index assessed using L3-CT as a prognostic marker of clinical outcomes in pancreatic cancer patients undergoing surgery: a systematic review and meta-analysis. Int J Surg 110:6126\u20136134","journal-title":"Int J Surg"},{"key":"2915_CR159","doi-asserted-by":"publisher","first-page":"1315097","DOI":"10.3389\/fnut.2023.1315097","volume":"10","author":"L Zhong","year":"2023","unstructured":"Zhong L, Liu J, Xia M et al (2023) Effect of sarcopenia on survival in patients after pancreatic surgery: a systematic review and meta-analysis. Front Nutr 10:1315097","journal-title":"Front Nutr"},{"key":"2915_CR160","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/wjs.12451","volume":"49","author":"R Matsui","year":"2025","unstructured":"Matsui R, Yonezu K, Rifu K et al (2025) Impact of sarcopenic obesity on postoperative outcomes in patients with oesophago-gastric cancer: a systematic review and meta-analysis. World J Surg 49:459\u2013471","journal-title":"World J Surg"},{"key":"2915_CR161","doi-asserted-by":"publisher","first-page":"101898","DOI":"10.1016\/j.gassur.2024.101898","volume":"29","author":"C Zhan","year":"2025","unstructured":"Zhan C, Bu J, Li S et al (2025) Postoperative skeletal muscle loss as a prognostic indicator of clinical outcomes in patients with gastric cancer: a systematic review and meta-analysis. J Gastrointest Surg 29:101898","journal-title":"J Gastrointest Surg"},{"key":"2915_CR162","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1007\/s00535-022-01923-2","volume":"57","author":"H Hisada","year":"2022","unstructured":"Hisada H, Tsuji Y, Obata M et al (2022) The impact of sarcopenia on short- and long-term outcomes of endoscopic submucosal dissection for early gastric cancer. J Gastroenterol 57:952\u2013961","journal-title":"J Gastroenterol"},{"key":"2915_CR163","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s10147-021-02112-6","volume":"27","author":"N Ito","year":"2022","unstructured":"Ito N, Funasaka K, Miyahara R et al (2022) Relationship between psoas muscle index and long-term survival in older patients aged \u2265 80 years after endoscopic submucosal dissection for gastric cancer. Int J Clin Oncol 27:729\u2013738","journal-title":"Int J Clin Oncol"},{"key":"2915_CR164","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1159\/000514275","volume":"39","author":"M Arao","year":"2021","unstructured":"Arao M, Mizutani T, Ozawa N et al (2021) Skeletal muscle depletion: a risk factor for pneumonia following gastric endoscopic submucosal dissection in elderly patients. Dig Dis 39:435\u2013443","journal-title":"Dig Dis"},{"key":"2915_CR165","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41598-022-27238-z","volume":"13","author":"Y Guo","year":"2023","unstructured":"Guo Y, Ren Y, Zhu L et al (2023) Association between sarcopenia and clinical outcomes in patients with hepatocellular carcinoma: an updated meta-analysis. Sci Rep 13:934","journal-title":"Sci Rep"},{"key":"2915_CR166","first-page":"389","volume":"16","author":"J Long","year":"2024","unstructured":"Long J, Zhang X, Mi W et al (2024) The predictive value of sarcopenia and myosteatosis in trans-arterial (chemo)-embolization treated HCC patients. Aging (Albany NY) 16:389\u2013401","journal-title":"Aging (Albany NY)"},{"key":"2915_CR167","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16020319","author":"YC Chen","year":"2024","unstructured":"Chen YC, Kuo MH, Hsu CS et al (2024) Impact of low muscle mass on hepatocellular carcinoma patients undergoing transcatheter liver-directed therapies: systematic review & meta-analysis. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16020319","journal-title":"Cancers (Basel)"},{"key":"2915_CR168","doi-asserted-by":"publisher","first-page":"e20455","DOI":"10.1097\/MD.0000000000020455","volume":"99","author":"WS Yeh","year":"2020","unstructured":"Yeh WS, Chiang PL, Kee KM et al (2020) Pre-sarcopenia is the prognostic factor of overall survival in early-stage hepatoma patients undergoing radiofrequency ablation. Medicine (Baltimore) 99:e20455","journal-title":"Medicine (Baltimore)"},{"key":"2915_CR169","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/jhbp.970","volume":"28","author":"Y Koya","year":"2021","unstructured":"Koya Y, Shibata M, Oe S et al (2021) Impact of sarcopenia on recurrent biliary obstruction after insertion of self-expandable metallic stent in patients with malignant biliary obstruction. J Hepatobiliary Pancreat Sci 28:572\u2013580","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2915_CR170","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s10147-023-02455-2","volume":"29","author":"T Emori","year":"2024","unstructured":"Emori T, Itonaga M, Ashida R et al (2024) Impact of sarcopenia on recurrent biliary obstruction after EUS-guided biliary drainage in patients with malignant biliary obstruction. Int J Clin Oncol 29:286\u2013296","journal-title":"Int J Clin Oncol"},{"key":"2915_CR171","doi-asserted-by":"publisher","DOI":"10.3390\/nu15030727","author":"M Cintoni","year":"2023","unstructured":"Cintoni M, Grassi F, Palombaro M et al (2023) Nutritional interventions during chemotherapy for pancreatic cancer: a systematic review of prospective studies. Nutrients. https:\/\/doi.org\/10.3390\/nu15030727","journal-title":"Nutrients"},{"key":"2915_CR172","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1016\/j.clnu.2024.06.037","volume":"43","author":"PN Klassen","year":"2024","unstructured":"Klassen PN, Mazurak VC, Baracos V et al (2024) Dose optimization of pancreatic enzyme replacement therapy is essential to mitigate muscle loss in patients with advanced pancreatic cancer and exocrine pancreatic insufficiency. Clin Nutr 43:1900\u20131906","journal-title":"Clin Nutr"},{"key":"2915_CR173","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00330-023-09974-6","volume":"34","author":"S Nowak","year":"2024","unstructured":"Nowak S, Kloth C, Theis M et al (2024) Deep learning-based assessment of CT markers of sarcopenia and myosteatosis for outcome assessment in patients with advanced pancreatic cancer after high-intensity focused ultrasound treatment. Eur Radiol 34:279\u2013286","journal-title":"Eur Radiol"},{"key":"2915_CR174","first-page":"469","volume":"24","author":"JLC Lee","year":"2016","unstructured":"Lee JLC, Leong LP, Lim SL (2016) Nutrition intervention approaches to reduce malnutrition in oncology patients: a systematic review. Support Care Cancer 24:469\u2013480","journal-title":"Support Care Cancer"},{"key":"2915_CR175","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.clnu.2014.04.007","volume":"33","author":"NE Deutz","year":"2014","unstructured":"Deutz NE, Bauer JM, Barazzoni R et al (2014) Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group. Clin Nutr 33:929\u2013936","journal-title":"Clin Nutr"},{"key":"2915_CR176","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1634\/theoncologist.2011-0133","volume":"16","author":"LM Oldervoll","year":"2011","unstructured":"Oldervoll LM, Loge JH, Lydersen S et al (2011) Physical exercise for cancer patients with advanced disease: a randomized controlled trial. Oncologist 16:1649\u20131657","journal-title":"Oncologist"},{"key":"2915_CR177","doi-asserted-by":"publisher","first-page":"b3410","DOI":"10.1136\/bmj.b3410","volume":"339","author":"L Adamsen","year":"2009","unstructured":"Adamsen L, Quist M, Andersen C et al (2009) Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial. BMJ 339:b3410","journal-title":"BMJ"},{"key":"2915_CR178","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1365-277X.2011.01189.x","volume":"24","author":"C Baldwin","year":"2011","unstructured":"Baldwin C, Spiro A, McGough C et al (2011) Simple nutritional intervention in patients with advanced cancers of the gastrointestinal tract, non-small cell lung cancers or mesothelioma and weight loss receiving chemotherapy: a randomised controlled trial. J Hum Nutr Diet 24:431\u2013440","journal-title":"J Hum Nutr Diet"},{"key":"2915_CR179","doi-asserted-by":"publisher","first-page":"e108687","DOI":"10.1371\/journal.pone.0108687","volume":"9","author":"I Bourdel-Marchasson","year":"2014","unstructured":"Bourdel-Marchasson I, Blanc-Bisson C, Doussau A et al (2014) Nutritional advice in older patients at risk of malnutrition during treatment for chemotherapy: a two-year randomized controlled trial. PLoS ONE 9:e108687","journal-title":"PLoS ONE"},{"key":"2915_CR180","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1634\/theoncologist.2010-0019","volume":"15","author":"E Del Fabbro","year":"2010","unstructured":"Del Fabbro E (2010) More is better: a multimodality approach to cancer cachexia. Oncologist 15:119\u2013121","journal-title":"Oncologist"},{"key":"2915_CR181","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1002\/cncr.32406","volume":"125","author":"S Hamauchi","year":"2019","unstructured":"Hamauchi S, Furuse J, Takano T et al (2019) A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia. Cancer 125:4294\u20134302","journal-title":"Cancer"},{"key":"2915_CR182","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s10120-025-01637-3","volume":"28","author":"Y Yanagimoto","year":"2025","unstructured":"Yanagimoto Y, Yamashita K, Kawabata R et al (2025) Effect of anamorelin on body weight in patients with gastric cancer-associated cachexia: an observational study. Gastric Cancer 28:945\u2013954","journal-title":"Gastric Cancer"},{"key":"2915_CR183","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1200\/JCO.20.00611","volume":"38","author":"EJ Roeland","year":"2020","unstructured":"Roeland EJ, Bohlke K, Baracos VE et al (2020) Management of cancer cachexia: ASCO guideline. J Clin Oncol 38:2438\u20132453","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02915-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-025-02915-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02915-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T20:02:01Z","timestamp":1762718521000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-025-02915-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,9]]},"references-count":183,"alternative-id":["2915"],"URL":"https:\/\/doi.org\/10.1007\/s10147-025-02915-x","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,9]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest regarding the publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}